100 related articles for article (PubMed ID: 3191482)
1. Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.
Stacker SA; Thompson CH; Sacks NP; Tjandra J; Lowe MG; Bishop J; McKenzie IF
Cancer Res; 1988 Dec; 48(24 Pt 1):7060-6. PubMed ID: 3191482
[TBL] [Abstract][Full Text] [Related]
2. Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.
Stacker SA; Thompson CH; Lowe MG; Sacks NP; Golder J; Carmen H; McKenzie IF
Dev Biol Stand; 1987; 67():91-6. PubMed ID: 3609486
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.
Linsley PS; Ochs V; Laska S; Horn D; Ring DB; Frankel AE; Brown JP
Cancer Res; 1986 Oct; 46(10):5444-50. PubMed ID: 2428478
[TBL] [Abstract][Full Text] [Related]
4. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
Bray KR; Koda JE; Gaur PK
Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
[TBL] [Abstract][Full Text] [Related]
5. MAM-6 antigen, a new serum marker for breast cancer monitoring.
Hilkens J; Kroezen V; Bonfrer JM; De Jong-Bakker M; Bruning PF
Cancer Res; 1986 May; 46(5):2582-7. PubMed ID: 3697998
[TBL] [Abstract][Full Text] [Related]
6. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer.
Iacobelli S; Arnò E; D'Orazio A; Coletti G
Cancer Res; 1986 Jun; 46(6):3005-10. PubMed ID: 3516389
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
[TBL] [Abstract][Full Text] [Related]
8. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22.
Papsidero LD; Nemoto T; Croghan GA; Chu TM
Cancer Res; 1984 Oct; 44(10):4653-7. PubMed ID: 6088042
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
10. [MSA--a new sensitive tumor marker in breast carcinoma].
Zahm DM; Greinke C; Nöschel H
Zentralbl Gynakol; 1996; 118(12):659-64. PubMed ID: 9082702
[TBL] [Abstract][Full Text] [Related]
11. Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
Stacker SA; Tjandra JJ; Xing PX; Walker ID; Thompson CH; McKenzie IF
Br J Cancer; 1989 Apr; 59(4):544-53. PubMed ID: 2469454
[TBL] [Abstract][Full Text] [Related]
12. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
[TBL] [Abstract][Full Text] [Related]
13. Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.
Tjandra JJ; Russell IS; Collins JP; Stacker SA; McKenzie IF
Br J Surg; 1988 Aug; 75(8):811-7. PubMed ID: 3048535
[TBL] [Abstract][Full Text] [Related]
14. The use of human monoclonal antibody to detect serum antigen in patients with breast cancer.
Strelkauskas AJ; Aldenderfer PH; Warner GA
Anticancer Res; 1989; 9(6):1863-8. PubMed ID: 2627133
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating adenocarcinoma-associated antigen in the sera of cancer patients with a monoclonal antibody.
Hinoda Y; Imai K; Endo T; Yamashita T; Yachi A
Jpn J Cancer Res; 1985 Dec; 76(12):1203-11. PubMed ID: 2419298
[TBL] [Abstract][Full Text] [Related]
16. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody PR92 with restricted specificity for tumor-associated antigen of prostate and breast carcinoma.
Kim YD; Robinson DY; Tomita JT
Cancer Res; 1988 Aug; 48(16):4543-8. PubMed ID: 3396007
[TBL] [Abstract][Full Text] [Related]
18. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
Salinas FA; Wee KH; Ceriani RL
Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.
Stacker SA; Sacks NP; Golder J; Tjandra JJ; Thompson CH; Smithyman A; McKenzie IF
Br J Cancer; 1988 Mar; 57(3):298-303. PubMed ID: 3355770
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of a tumor-associated antigen CA 15-3 in the sera of patients with breast cancer].
Ogawa T; Izuo M; Morita H; Ishida T; Iino Y; Hoshino K; Yokoe T; Suzuki H; Murata S; Matsuzaki S
Gan No Rinsho; 1986 Jan; 32(1):27-32. PubMed ID: 3456454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
